MMWR Recommendations and Reports Vol. 65, No. RR-1 March 18, 2016 |
In this report |
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016 Deborah Dowell, MD; Tamara M. Haegerich, PhD; Roger Chou, MD. MMWR Recomm Rep 2016;65:1–49 This guideline provides recommendations for primary care providers who are prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life care. The guideline addresses 1) when to initiate or continue opioids for chronic pain; 2) opioid selection, dosage, duration, follow-up, and discontinuation; and 3) assessing risk and addressing harms of opioid use. This guideline is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including abuse, dependence, overdose, and death. |
MMWR Masthead |
Department of Health and Human Services Centers for Disease Control and Prevention |
The CDC has reached 1 million email subscribers. Thank you for your support. Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates Questions or problems? Please contact support@xxxxxxxxxxxxxxx. |
This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636) |